incretin effect glp-1 physiology and pathophysiology from an Asian perspective - Cho - 2015 - Journal of Diabetes Investigation GLP-1 is released from the
Description
The evidence base for GLP-1 agonists in binge eating disorder remains preliminary, with most data coming from case reports, small case series, and secondary analyses rather than large randomized controlled trials specifically designed for BED
Resting Energy Expenditure and Metabolic Adaptation One of the bodys natural responses to weight loss is a reduction in resting energy expenditure
The conversation around GLP-1 medications is quickly moving beyond healthcare and into everyday behavior including how people dine out
A very large portion of the adult population could potentially meet clinical criteria for these drugs, which makes it imperative for plan sponsors to think strategically not reactively about how they are managed
